Quality assurance in molecular genetic testing laboratories

JAMA

Volumn 281, Issue 9, 1999, Pages 835-840

  McGovern, Margaret M ^a,c   Benach, Marta O ^a   Wallenstein, Sylvan ^a   Desnick, Robert J ^a   Keenlyside, Richard ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CERTIFICATION; EDUCATION; GENETIC ANALYSIS; GENETIC COUNSELING; GOOD LABORATORY PRACTICE; HOSPITAL LABORATORY; INFORMED CONSENT; LABORATORY PERSONNEL; MOLECULAR GENETICS; PRIORITY JOURNAL; PRIVACY; QUALITY CONTROL;

EID: 0033518855     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.281.9.835     Document Type: Article

References (18)

1. Struewing JP, Hartge P, Wacholder S, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med. 1997;336:1401-1408.
2. Szabo CI, King MC. Population genetics of BRCA1 and BRCA2. Am J Hum Genet 1997;60:1013-1020.
3. Kinzler KW, Vogelstein B. Lessons from hereditary colon cancer. Cell. 1996;87:159-170.
4. Larkin M. "Personalised" drug therapy could be near. Lancet. 1998;351:1937.
5. Krynetski EY, Evans WE. Pharmacogenetics of cancer therapy. Am J Hum Genet. 1998;63:11-16.
6. Holtzman NA, Watson MS, eds. Promoting Safe and Effective Genetic Testing in the United States: Final Report of the Task Force on Genetic Testing. Washington, DC: National Academy Press; 1997.
7. Andrews L, Fullarton JE, Holtzman NA, Motulsky AG, eds. Assessing Genetic Risks: Implications for Health and Social Policy. Washington, DC: National Academy Press; 1994.
8. US Congress, Office of Technology Assessment. Cystic Fibrosis and DNA Tests. Washington, DC: US Government Printing Office; August 1992. Publication OTA-BA-532.
9. Hudson KL, Rothenburg KH, Andrews LB, Kahn MJE, Collins FS. Genetic discrimination and health insurance: an urgent need for reform. Science. 1995; 270:391-393.
10. Medicare, Medicaid and CLIA programs: regulations implementing Clinical Laboratory Improvement Amendments of 1988 (CLIA), 57 Federal Register7002 (1992).
11. 42 Federal Register 892 (1995) (codified at 42 CFR §493).
12. Children's Hospital and Regional Medical Center and University of Washington School of Medicine. HELIX directory. Available at: http:// www.hslib.washington.edu/helix. Accessed January 22, 1999.
13. Standards and Guidelines: Clinical Genetics Laboratories, The American College of Human Genetics Laboratory Practice Committee, 1993. ACMG Web site: http://www.arvo.org/genetics/acmg.
14. 42 Federal Register 888 (1995) (codified at 42 CFR §493).
15. Watson MS. Current activities involving economic, regulatory, and practice issues in molecular genetic testing. Diagn Mol Pathol. 1995;4:233-234.
16. Verma RS, Luke S. Variations in alphoid DNA sequences escape detection of aneuploidy at interphase by FISH technique. Genomics. 1992;14:113-116.
17. Yankowitz J, Li S, Weiner CP. Polymerase chain reaction determination of RhC, Rhc, and RhE blood types. Am J Obstet Gynecol. 1997;176:1107-1111.
18. Fukimara FK, Northrup H, Beaudet AL, O'Brien WE. Genotyping errors with the polymerase chain reaction. N Engl J Med. 1990;322:61.